nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—Alkylating Activity—Dacarbazine—muscle cancer	0.509	1	CiPCiCtD
Procarbazine—hematologic cancer—muscle cancer	0.351	1	CtDrD
Procarbazine—XDH—Doxorubicin—muscle cancer	0.0602	0.601	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—muscle cancer	0.04	0.399	CbGbCtD
Procarbazine—XDH—Effects of Nitric Oxide—MB—muscle cancer	0.00323	0.856	CbGpPWpGaD
Procarbazine—Thrombosis—Doxorubicin—muscle cancer	0.000142	0.00396	CcSEcCtD
Procarbazine—Petechiae—Methotrexate—muscle cancer	0.000141	0.00393	CcSEcCtD
Procarbazine—Nystagmus—Doxorubicin—muscle cancer	0.00014	0.00392	CcSEcCtD
Procarbazine—Photosensitivity reaction—Vincristine—muscle cancer	0.000137	0.00382	CcSEcCtD
Procarbazine—Haemoptysis—Doxorubicin—muscle cancer	0.000135	0.00378	CcSEcCtD
Procarbazine—CYP1B1—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000135	0.0358	CbGpPWpGaD
Procarbazine—Pneumonia—Vincristine—muscle cancer	0.000134	0.00375	CcSEcCtD
Procarbazine—Pleural effusion—Doxorubicin—muscle cancer	0.000131	0.00366	CcSEcCtD
Procarbazine—Neuropathy peripheral—Vincristine—muscle cancer	0.000131	0.00365	CcSEcCtD
Procarbazine—Stomatitis—Vincristine—muscle cancer	0.00013	0.00363	CcSEcCtD
Procarbazine—Sweating—Vincristine—muscle cancer	0.000128	0.00357	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.000126	0.00353	CcSEcCtD
Procarbazine—Flushing—Dactinomycin—muscle cancer	0.000124	0.00348	CcSEcCtD
Procarbazine—Dysarthria—Methotrexate—muscle cancer	0.000122	0.00342	CcSEcCtD
Procarbazine—Dysphonia—Doxorubicin—muscle cancer	0.000122	0.0034	CcSEcCtD
Procarbazine—Petechiae—Doxorubicin—muscle cancer	0.000122	0.0034	CcSEcCtD
Procarbazine—Dysphagia—Etoposide—muscle cancer	0.000121	0.00339	CcSEcCtD
Procarbazine—Chills—Dactinomycin—muscle cancer	0.00012	0.00336	CcSEcCtD
Procarbazine—Hallucination—Vincristine—muscle cancer	0.000119	0.00333	CcSEcCtD
Procarbazine—Alopecia—Dactinomycin—muscle cancer	0.000118	0.00331	CcSEcCtD
Procarbazine—Sweating increased—Etoposide—muscle cancer	0.000118	0.0033	CcSEcCtD
Procarbazine—Neoplasm malignant—Doxorubicin—muscle cancer	0.000117	0.00328	CcSEcCtD
Procarbazine—Pancytopenia—Etoposide—muscle cancer	0.000115	0.00322	CcSEcCtD
Procarbazine—Amenorrhoea—Doxorubicin—muscle cancer	0.000114	0.00319	CcSEcCtD
Procarbazine—Melaena—Methotrexate—muscle cancer	0.000113	0.00316	CcSEcCtD
Procarbazine—Pneumonia—Etoposide—muscle cancer	0.000109	0.00304	CcSEcCtD
Procarbazine—Nocturia—Doxorubicin—muscle cancer	0.000108	0.00302	CcSEcCtD
Procarbazine—Anaemia—Dactinomycin—muscle cancer	0.000108	0.00301	CcSEcCtD
Procarbazine—Dysarthria—Doxorubicin—muscle cancer	0.000106	0.00296	CcSEcCtD
Procarbazine—Neuropathy peripheral—Etoposide—muscle cancer	0.000106	0.00296	CcSEcCtD
Procarbazine—Alopecia—Vincristine—muscle cancer	0.000106	0.00296	CcSEcCtD
Procarbazine—Coma—Methotrexate—muscle cancer	0.000106	0.00296	CcSEcCtD
Procarbazine—Stomatitis—Etoposide—muscle cancer	0.000105	0.00294	CcSEcCtD
Procarbazine—Jaundice—Etoposide—muscle cancer	0.000105	0.00294	CcSEcCtD
Procarbazine—Leukopenia—Dactinomycin—muscle cancer	0.000104	0.00292	CcSEcCtD
Procarbazine—Gynaecomastia—Methotrexate—muscle cancer	0.000104	0.00289	CcSEcCtD
Procarbazine—Myalgia—Dactinomycin—muscle cancer	9.94e-05	0.00278	CcSEcCtD
Procarbazine—Melaena—Doxorubicin—muscle cancer	9.79e-05	0.00274	CcSEcCtD
Procarbazine—Anaemia—Vincristine—muscle cancer	9.64e-05	0.00269	CcSEcCtD
Procarbazine—Photosensitivity—Methotrexate—muscle cancer	9.57e-05	0.00267	CcSEcCtD
Procarbazine—Oedema—Dactinomycin—muscle cancer	9.53e-05	0.00266	CcSEcCtD
Procarbazine—Infection—Dactinomycin—muscle cancer	9.46e-05	0.00264	CcSEcCtD
Procarbazine—Neuropathy—Doxorubicin—muscle cancer	9.41e-05	0.00263	CcSEcCtD
Procarbazine—Leukopenia—Vincristine—muscle cancer	9.33e-05	0.00261	CcSEcCtD
Procarbazine—Thrombocytopenia—Dactinomycin—muscle cancer	9.33e-05	0.00261	CcSEcCtD
Procarbazine—Coma—Doxorubicin—muscle cancer	9.16e-05	0.00256	CcSEcCtD
Procarbazine—Anorexia—Dactinomycin—muscle cancer	9.08e-05	0.00254	CcSEcCtD
Procarbazine—Convulsion—Vincristine—muscle cancer	9.04e-05	0.00252	CcSEcCtD
Procarbazine—Flushing—Etoposide—muscle cancer	9.01e-05	0.00252	CcSEcCtD
Procarbazine—Hypertension—Vincristine—muscle cancer	9e-05	0.00252	CcSEcCtD
Procarbazine—Myalgia—Vincristine—muscle cancer	8.88e-05	0.00248	CcSEcCtD
Procarbazine—Chills—Etoposide—muscle cancer	8.71e-05	0.00243	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	8.68e-05	0.00242	CcSEcCtD
Procarbazine—Alopecia—Etoposide—muscle cancer	8.57e-05	0.0024	CcSEcCtD
Procarbazine—Lethargy—Methotrexate—muscle cancer	8.57e-05	0.0024	CcSEcCtD
Procarbazine—Oedema—Vincristine—muscle cancer	8.51e-05	0.00238	CcSEcCtD
Procarbazine—Infection—Vincristine—muscle cancer	8.46e-05	0.00236	CcSEcCtD
Procarbazine—Thrombocytopenia—Vincristine—muscle cancer	8.33e-05	0.00233	CcSEcCtD
Procarbazine—Hepatic function abnormal—Doxorubicin—muscle cancer	8.32e-05	0.00233	CcSEcCtD
Procarbazine—Photosensitivity—Doxorubicin—muscle cancer	8.29e-05	0.00232	CcSEcCtD
Procarbazine—Decreased appetite—Dactinomycin—muscle cancer	8.28e-05	0.00231	CcSEcCtD
Procarbazine—Hyperhidrosis—Vincristine—muscle cancer	8.23e-05	0.0023	CcSEcCtD
Procarbazine—Fatigue—Dactinomycin—muscle cancer	8.21e-05	0.00229	CcSEcCtD
Procarbazine—Pain—Dactinomycin—muscle cancer	8.15e-05	0.00228	CcSEcCtD
Procarbazine—Vascular purpura—Doxorubicin—muscle cancer	8.13e-05	0.00227	CcSEcCtD
Procarbazine—Anorexia—Vincristine—muscle cancer	8.11e-05	0.00227	CcSEcCtD
Procarbazine—Hypotension—Vincristine—muscle cancer	7.95e-05	0.00222	CcSEcCtD
Procarbazine—Ataxia—Methotrexate—muscle cancer	7.9e-05	0.00221	CcSEcCtD
Procarbazine—Feeling abnormal—Dactinomycin—muscle cancer	7.85e-05	0.00219	CcSEcCtD
Procarbazine—Anaemia—Etoposide—muscle cancer	7.81e-05	0.00218	CcSEcCtD
Procarbazine—Gastrointestinal pain—Dactinomycin—muscle cancer	7.79e-05	0.00218	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Vincristine—muscle cancer	7.75e-05	0.00217	CcSEcCtD
Procarbazine—Insomnia—Vincristine—muscle cancer	7.7e-05	0.00215	CcSEcCtD
Procarbazine—Paraesthesia—Vincristine—muscle cancer	7.64e-05	0.00214	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	7.57e-05	0.00211	CcSEcCtD
Procarbazine—Leukopenia—Etoposide—muscle cancer	7.56e-05	0.00211	CcSEcCtD
Procarbazine—Purpura—Doxorubicin—muscle cancer	7.55e-05	0.00211	CcSEcCtD
Procarbazine—Body temperature increased—Dactinomycin—muscle cancer	7.53e-05	0.0021	CcSEcCtD
Procarbazine—Abdominal pain—Dactinomycin—muscle cancer	7.53e-05	0.0021	CcSEcCtD
Procarbazine—Loss of consciousness—Etoposide—muscle cancer	7.42e-05	0.00207	CcSEcCtD
Procarbazine—Lethargy—Doxorubicin—muscle cancer	7.42e-05	0.00207	CcSEcCtD
Procarbazine—Decreased appetite—Vincristine—muscle cancer	7.4e-05	0.00207	CcSEcCtD
Procarbazine—Cough—Etoposide—muscle cancer	7.37e-05	0.00206	CcSEcCtD
Procarbazine—Fatigue—Vincristine—muscle cancer	7.34e-05	0.00205	CcSEcCtD
Procarbazine—Convulsion—Etoposide—muscle cancer	7.32e-05	0.00205	CcSEcCtD
Procarbazine—Hypertension—Etoposide—muscle cancer	7.29e-05	0.00204	CcSEcCtD
Procarbazine—Pain—Vincristine—muscle cancer	7.28e-05	0.00203	CcSEcCtD
Procarbazine—Constipation—Vincristine—muscle cancer	7.28e-05	0.00203	CcSEcCtD
Procarbazine—Diplopia—Doxorubicin—muscle cancer	7.28e-05	0.00203	CcSEcCtD
Procarbazine—Eosinophilia—Methotrexate—muscle cancer	7.19e-05	0.00201	CcSEcCtD
Procarbazine—Pancreatitis—Methotrexate—muscle cancer	7.12e-05	0.00199	CcSEcCtD
Procarbazine—Hypersensitivity—Dactinomycin—muscle cancer	7.02e-05	0.00196	CcSEcCtD
Procarbazine—Gastrointestinal pain—Vincristine—muscle cancer	6.96e-05	0.00194	CcSEcCtD
Procarbazine—Confusional state—Etoposide—muscle cancer	6.95e-05	0.00194	CcSEcCtD
Procarbazine—Pancytopenia—Methotrexate—muscle cancer	6.9e-05	0.00193	CcSEcCtD
Procarbazine—Infection—Etoposide—muscle cancer	6.85e-05	0.00191	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—muscle cancer	6.84e-05	0.00191	CcSEcCtD
Procarbazine—Asthenia—Dactinomycin—muscle cancer	6.83e-05	0.00191	CcSEcCtD
Procarbazine—Thrombocytopenia—Etoposide—muscle cancer	6.75e-05	0.00189	CcSEcCtD
Procarbazine—Tachycardia—Etoposide—muscle cancer	6.73e-05	0.00188	CcSEcCtD
Procarbazine—Abdominal pain—Vincristine—muscle cancer	6.73e-05	0.00188	CcSEcCtD
Procarbazine—Body temperature increased—Vincristine—muscle cancer	6.73e-05	0.00188	CcSEcCtD
Procarbazine—Hyperhidrosis—Etoposide—muscle cancer	6.66e-05	0.00186	CcSEcCtD
Procarbazine—Photosensitivity reaction—Methotrexate—muscle cancer	6.63e-05	0.00185	CcSEcCtD
Procarbazine—Anorexia—Etoposide—muscle cancer	6.57e-05	0.00184	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	6.55e-05	0.00183	CcSEcCtD
Procarbazine—Diarrhoea—Dactinomycin—muscle cancer	6.52e-05	0.00182	CcSEcCtD
Procarbazine—Pneumonia—Methotrexate—muscle cancer	6.51e-05	0.00182	CcSEcCtD
Procarbazine—Drowsiness—Methotrexate—muscle cancer	6.47e-05	0.00181	CcSEcCtD
Procarbazine—Hypotension—Etoposide—muscle cancer	6.44e-05	0.0018	CcSEcCtD
Procarbazine—Stomatitis—Methotrexate—muscle cancer	6.31e-05	0.00176	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—muscle cancer	6.29e-05	0.00176	CcSEcCtD
Procarbazine—Hypersensitivity—Vincristine—muscle cancer	6.27e-05	0.00175	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—muscle cancer	6.23e-05	0.00174	CcSEcCtD
Procarbazine—Sweating—Methotrexate—muscle cancer	6.21e-05	0.00173	CcSEcCtD
Procarbazine—Paraesthesia—Etoposide—muscle cancer	6.19e-05	0.00173	CcSEcCtD
Procarbazine—Haematuria—Methotrexate—muscle cancer	6.17e-05	0.00172	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—muscle cancer	6.16e-05	0.00172	CcSEcCtD
Procarbazine—Somnolence—Etoposide—muscle cancer	6.13e-05	0.00171	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—muscle cancer	6.13e-05	0.00171	CcSEcCtD
Procarbazine—Epistaxis—Methotrexate—muscle cancer	6.11e-05	0.00171	CcSEcCtD
Procarbazine—Asthenia—Vincristine—muscle cancer	6.11e-05	0.00171	CcSEcCtD
Procarbazine—Vomiting—Dactinomycin—muscle cancer	6.06e-05	0.00169	CcSEcCtD
Procarbazine—Rash—Dactinomycin—muscle cancer	6.01e-05	0.00168	CcSEcCtD
Procarbazine—Decreased appetite—Etoposide—muscle cancer	5.99e-05	0.00167	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—PTGS2—muscle cancer	5.99e-05	0.0159	CbGpPWpGaD
Procarbazine—Pancytopenia—Doxorubicin—muscle cancer	5.97e-05	0.00167	CcSEcCtD
Procarbazine—Fatigue—Etoposide—muscle cancer	5.94e-05	0.00166	CcSEcCtD
Procarbazine—Pain—Etoposide—muscle cancer	5.9e-05	0.00165	CcSEcCtD
Procarbazine—Constipation—Etoposide—muscle cancer	5.9e-05	0.00165	CcSEcCtD
Procarbazine—Haemoglobin—Methotrexate—muscle cancer	5.84e-05	0.00163	CcSEcCtD
Procarbazine—Diarrhoea—Vincristine—muscle cancer	5.82e-05	0.00163	CcSEcCtD
Procarbazine—Haemorrhage—Methotrexate—muscle cancer	5.81e-05	0.00162	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—muscle cancer	5.81e-05	0.00162	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—muscle cancer	5.74e-05	0.0016	CcSEcCtD
Procarbazine—Feeling abnormal—Etoposide—muscle cancer	5.68e-05	0.00159	CcSEcCtD
Procarbazine—Nausea—Dactinomycin—muscle cancer	5.66e-05	0.00158	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—muscle cancer	5.64e-05	0.00158	CcSEcCtD
Procarbazine—Gastrointestinal pain—Etoposide—muscle cancer	5.64e-05	0.00158	CcSEcCtD
Procarbazine—Dizziness—Vincristine—muscle cancer	5.63e-05	0.00157	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—muscle cancer	5.61e-05	0.00157	CcSEcCtD
Procarbazine—CYP1B1—Tryptophan metabolism—MDM2—muscle cancer	5.59e-05	0.0148	CbGpPWpGaD
Procarbazine—Neuropathy peripheral—Doxorubicin—muscle cancer	5.5e-05	0.00154	CcSEcCtD
Procarbazine—Urticaria—Etoposide—muscle cancer	5.48e-05	0.00153	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—muscle cancer	5.46e-05	0.00153	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—muscle cancer	5.46e-05	0.00153	CcSEcCtD
Procarbazine—Abdominal pain—Etoposide—muscle cancer	5.45e-05	0.00152	CcSEcCtD
Procarbazine—Body temperature increased—Etoposide—muscle cancer	5.45e-05	0.00152	CcSEcCtD
Procarbazine—Vomiting—Vincristine—muscle cancer	5.41e-05	0.00151	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	5.39e-05	0.0143	CbGpPWpGaD
Procarbazine—Sweating—Doxorubicin—muscle cancer	5.37e-05	0.0015	CcSEcCtD
Procarbazine—Rash—Vincristine—muscle cancer	5.37e-05	0.0015	CcSEcCtD
Procarbazine—Dermatitis—Vincristine—muscle cancer	5.36e-05	0.0015	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—muscle cancer	5.35e-05	0.00149	CcSEcCtD
Procarbazine—Headache—Vincristine—muscle cancer	5.33e-05	0.00149	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—muscle cancer	5.29e-05	0.00148	CcSEcCtD
Procarbazine—Chills—Methotrexate—muscle cancer	5.22e-05	0.00146	CcSEcCtD
Procarbazine—Alopecia—Methotrexate—muscle cancer	5.14e-05	0.00144	CcSEcCtD
Procarbazine—Hypersensitivity—Etoposide—muscle cancer	5.08e-05	0.00142	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—muscle cancer	5.06e-05	0.00141	CcSEcCtD
Procarbazine—Nausea—Vincristine—muscle cancer	5.06e-05	0.00141	CcSEcCtD
Procarbazine—CYP1B1—Arachidonic acid metabolism—PTGS2—muscle cancer	5.04e-05	0.0134	CbGpPWpGaD
Procarbazine—Haemorrhage—Doxorubicin—muscle cancer	5.03e-05	0.00141	CcSEcCtD
Procarbazine—Asthenia—Etoposide—muscle cancer	4.95e-05	0.00138	CcSEcCtD
Procarbazine—Pruritus—Etoposide—muscle cancer	4.88e-05	0.00136	CcSEcCtD
Procarbazine—Diarrhoea—Etoposide—muscle cancer	4.72e-05	0.00132	CcSEcCtD
Procarbazine—Anaemia—Methotrexate—muscle cancer	4.68e-05	0.00131	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—muscle cancer	4.67e-05	0.00131	CcSEcCtD
Procarbazine—Dizziness—Etoposide—muscle cancer	4.56e-05	0.00127	CcSEcCtD
Procarbazine—Leukopenia—Methotrexate—muscle cancer	4.53e-05	0.00127	CcSEcCtD
Procarbazine—Chills—Doxorubicin—muscle cancer	4.52e-05	0.00126	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—muscle cancer	4.5e-05	0.00126	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—muscle cancer	4.45e-05	0.00124	CcSEcCtD
Procarbazine—Cough—Methotrexate—muscle cancer	4.42e-05	0.00123	CcSEcCtD
Procarbazine—Convulsion—Methotrexate—muscle cancer	4.38e-05	0.00122	CcSEcCtD
Procarbazine—Vomiting—Etoposide—muscle cancer	4.38e-05	0.00122	CcSEcCtD
Procarbazine—Rash—Etoposide—muscle cancer	4.35e-05	0.00121	CcSEcCtD
Procarbazine—Dermatitis—Etoposide—muscle cancer	4.34e-05	0.00121	CcSEcCtD
Procarbazine—Headache—Etoposide—muscle cancer	4.32e-05	0.00121	CcSEcCtD
Procarbazine—Myalgia—Methotrexate—muscle cancer	4.31e-05	0.0012	CcSEcCtD
Procarbazine—Arthralgia—Methotrexate—muscle cancer	4.31e-05	0.0012	CcSEcCtD
Procarbazine—Tension—Doxorubicin—muscle cancer	4.3e-05	0.0012	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—muscle cancer	4.26e-05	0.00119	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	4.24e-05	0.0113	CbGpPWpGaD
Procarbazine—Confusional state—Methotrexate—muscle cancer	4.16e-05	0.00116	CcSEcCtD
Procarbazine—Infection—Methotrexate—muscle cancer	4.1e-05	0.00115	CcSEcCtD
Procarbazine—Nausea—Etoposide—muscle cancer	4.1e-05	0.00114	CcSEcCtD
Procarbazine—Anaemia—Doxorubicin—muscle cancer	4.05e-05	0.00113	CcSEcCtD
Procarbazine—Thrombocytopenia—Methotrexate—muscle cancer	4.04e-05	0.00113	CcSEcCtD
Procarbazine—Hyperhidrosis—Methotrexate—muscle cancer	3.99e-05	0.00112	CcSEcCtD
Procarbazine—Anorexia—Methotrexate—muscle cancer	3.94e-05	0.0011	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—muscle cancer	3.93e-05	0.0011	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—muscle cancer	3.92e-05	0.0011	CcSEcCtD
Procarbazine—Hypotension—Methotrexate—muscle cancer	3.86e-05	0.00108	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—muscle cancer	3.85e-05	0.00108	CcSEcCtD
Procarbazine—Cough—Doxorubicin—muscle cancer	3.82e-05	0.00107	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—muscle cancer	3.8e-05	0.00106	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—muscle cancer	3.78e-05	0.00106	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Methotrexate—muscle cancer	3.76e-05	0.00105	CcSEcCtD
Procarbazine—Insomnia—Methotrexate—muscle cancer	3.73e-05	0.00104	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—muscle cancer	3.73e-05	0.00104	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—muscle cancer	3.73e-05	0.00104	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—muscle cancer	3.72e-05	0.00104	CcSEcCtD
Procarbazine—Paraesthesia—Methotrexate—muscle cancer	3.71e-05	0.00104	CcSEcCtD
Procarbazine—Somnolence—Methotrexate—muscle cancer	3.67e-05	0.00103	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—muscle cancer	3.65e-05	0.00102	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—muscle cancer	3.61e-05	0.00101	CcSEcCtD
Procarbazine—Decreased appetite—Methotrexate—muscle cancer	3.59e-05	0.001	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—muscle cancer	3.58e-05	0.000999	CcSEcCtD
Procarbazine—Fatigue—Methotrexate—muscle cancer	3.56e-05	0.000995	CcSEcCtD
Procarbazine—Infection—Doxorubicin—muscle cancer	3.55e-05	0.000993	CcSEcCtD
Procarbazine—Pain—Methotrexate—muscle cancer	3.53e-05	0.000987	CcSEcCtD
Procarbazine—Shock—Doxorubicin—muscle cancer	3.52e-05	0.000983	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—muscle cancer	3.5e-05	0.000978	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—muscle cancer	3.49e-05	0.000975	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—muscle cancer	3.46e-05	0.000966	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—muscle cancer	3.41e-05	0.000952	CcSEcCtD
Procarbazine—Feeling abnormal—Methotrexate—muscle cancer	3.4e-05	0.000951	CcSEcCtD
Procarbazine—Gastrointestinal pain—Methotrexate—muscle cancer	3.38e-05	0.000944	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—muscle cancer	3.34e-05	0.000934	CcSEcCtD
Procarbazine—XDH—Metabolism—FH—muscle cancer	3.34e-05	0.00886	CbGpPWpGaD
Procarbazine—Urticaria—Methotrexate—muscle cancer	3.28e-05	0.000917	CcSEcCtD
Procarbazine—Body temperature increased—Methotrexate—muscle cancer	3.26e-05	0.000912	CcSEcCtD
Procarbazine—Abdominal pain—Methotrexate—muscle cancer	3.26e-05	0.000912	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	3.26e-05	0.00091	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—muscle cancer	3.23e-05	0.000904	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—muscle cancer	3.21e-05	0.000897	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—muscle cancer	3.18e-05	0.000888	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—muscle cancer	3.11e-05	0.000869	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—muscle cancer	3.08e-05	0.000861	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—muscle cancer	3.06e-05	0.000854	CcSEcCtD
Procarbazine—Pain—Doxorubicin—muscle cancer	3.06e-05	0.000854	CcSEcCtD
Procarbazine—Hypersensitivity—Methotrexate—muscle cancer	3.04e-05	0.00085	CcSEcCtD
Procarbazine—Asthenia—Methotrexate—muscle cancer	2.96e-05	0.000828	CcSEcCtD
Procarbazine—Feeling abnormal—Doxorubicin—muscle cancer	2.95e-05	0.000823	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—muscle cancer	2.92e-05	0.000817	CcSEcCtD
Procarbazine—Pruritus—Methotrexate—muscle cancer	2.92e-05	0.000816	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—muscle cancer	2.84e-05	0.000794	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—muscle cancer	2.83e-05	0.00079	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—muscle cancer	2.83e-05	0.00079	CcSEcCtD
Procarbazine—Diarrhoea—Methotrexate—muscle cancer	2.83e-05	0.000789	CcSEcCtD
Procarbazine—Dizziness—Methotrexate—muscle cancer	2.73e-05	0.000763	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—muscle cancer	2.63e-05	0.000736	CcSEcCtD
Procarbazine—Vomiting—Methotrexate—muscle cancer	2.63e-05	0.000734	CcSEcCtD
Procarbazine—Rash—Methotrexate—muscle cancer	2.6e-05	0.000728	CcSEcCtD
Procarbazine—Dermatitis—Methotrexate—muscle cancer	2.6e-05	0.000727	CcSEcCtD
Procarbazine—Headache—Methotrexate—muscle cancer	2.59e-05	0.000723	CcSEcCtD
Procarbazine—Asthenia—Doxorubicin—muscle cancer	2.57e-05	0.000717	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—muscle cancer	2.53e-05	0.000707	CcSEcCtD
Procarbazine—Nausea—Methotrexate—muscle cancer	2.45e-05	0.000685	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—muscle cancer	2.45e-05	0.000684	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—muscle cancer	2.36e-05	0.000661	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—muscle cancer	2.27e-05	0.000635	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.27e-05	0.00602	CbGpPWpGaD
Procarbazine—Rash—Doxorubicin—muscle cancer	2.25e-05	0.00063	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—muscle cancer	2.25e-05	0.000629	CcSEcCtD
Procarbazine—Headache—Doxorubicin—muscle cancer	2.24e-05	0.000626	CcSEcCtD
Procarbazine—Nausea—Doxorubicin—muscle cancer	2.12e-05	0.000593	CcSEcCtD
Procarbazine—XDH—Metabolism—MED12—muscle cancer	1.89e-05	0.00501	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—FH—muscle cancer	1.79e-05	0.00475	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ENO2—muscle cancer	1.72e-05	0.00456	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—MED12—muscle cancer	1.01e-05	0.00268	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ENO2—muscle cancer	9.21e-06	0.00245	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.2e-06	0.00191	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PTGS2—muscle cancer	5.99e-06	0.00159	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PTGS2—muscle cancer	3.21e-06	0.000852	CbGpPWpGaD
